Colorectal cancer (CRC) is one of the most common malignancies worldwide. China,
Europe and northern America account for more than half of the new CRC cases and …

Mortality from colorectal cancer is reduced through screening and early detection; moreover,
removal of neoplastic lesions can reduce cancer incidence. While understanding of the risk …

Globally, colorectal cancer (CRC) is the third most commonly diagnosed malignancy and the
second leading cause of cancer death. Arising through three major pathways, including …

The incidence of sporadic young-onset colorectal cancer (yCRC) is increasing. A significant
knowledge gap exists in the gut microbiota and its diagnostic value for yCRC patients …

Colorectal cancer (CRC) is the third most commonly diagnosed cancer in the world. The
incidence and mortality show wide geographical variations. Screening is recommended to …

Altered metabolism of lipids is currently considered a hallmark characteristic of many
malignancies, including colorectal cancer (CRC). Lipids are a large group of metabolites …

The use of the fecal occult blood test (FOBT) for colorectal cancer (CRC) screening is
supported by randomized trials demonstrating effectiveness in cancer prevention and widely …

Colorectal cancer is one of the leading causes of cancer-related morbidity and mortality.
Main risk factors include advanced age, family history, male sex, and lifestyle factors …

Screening, followed by colonoscopic polypectomy (or surgery for malignant lesions),
prevents incident colorectal cancer and mortality. However, there are variations in effective …

Colorectal cancer (CRC) is the third most common cancer and the second leading cause of
cancer mortality worldwide. Emerging evidence indicates that tumour cells release …